Monilola Olayioye graduated from Technical University Braunschweig in biotechnology in 1996, after completing diploma studies at the Scripps Research Institute in San Diego.
Her PhD studies on ErbB receptor signaling with Nancy Hynes at the Friedrich Miescher Institute in Basel (1997-2000) were followed by postdoctoral work as an Embo fellow with Jane Visvader and Geoff Lindeman at the Walter and Eliza Hall Institute of Medical Research in Melbourne (2000-2003).
In 2005, supported by DFG and DKH start-up grants, she established an independent research group at the Institute of Cell Biology and Immunology at the University of Stuttgart focusing on START domain containing proteins in breast cancer. In 2010, Monilola Olayioye was nominated for a DFG Heisenberg professorship in Molecular Tumor Cell Biology and holds this tenured position since 2011 at the University of Stuttgart.
Her current research investigates oncogenic and tumor suppressive signaling networks in breast and colorectal cancer.